Navigation Links
Insmed to Present at Sixth Annual JMP Securities Healthcare Conference
Date:9/26/2011

MONMOUTH JUNCTION, N.J., Sept. 26, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, announced today that Timothy Whitten, President and CEO of Insmed, will be presenting a corporate overview at the Sixth Annual JMP Securities Healthcare Conference on Wednesday, September 28, 2011, at 11:30 AM ET, in New York.

A live audio webcast will be available on Insmed's website, http://www.insmed.com.  The webcast will also be archived for 90 days.

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases, and has a proprietary protein platform aimed at niche markets with high unmet medical need. Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial position, results of operations, the status and the results of preclinical studies and clinical trials and preclinical and clinical data described herein, the timing of responses to information and data requests from FDA, the development of our products, and the business strategies, plans and objectives of management, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  Our results may be affected by such factors as the receipt and
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
2. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
3. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
6. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
7. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
8. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
9. Insmed to Host Third Quarter 2010 Conference Call
10. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
11. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - ... , Italy , UK, Spain ) ... - Europe ( Germany , ... )" provides quantitative analysis of the transcatheter heart valves market in ... over the 2007–2020 period and key company share data by revenue in 2013 ...
(Date:9/23/2014)... , Sept. 23, 2014  SI-BONE, Inc., a ... iFuse Implant System, ® a minimally invasive surgical ... joint, today announced that the U.S. Patent and Trademark ... systems and methods for the fixation and fusion of ... fenestrated implant with a tapered distal end that may be placed from ...
(Date:9/23/2014)... IRVINE, Calif. , Sept. 23, 2014  Global ... technology to conquer some of the biggest healthcare challenges, ... simple and highly accurate blood test for the early ... the leading cause of cancer death. Typically, the symptoms ... advanced stage of cancer, where the chance of a ...
Breaking Medicine Technology:Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain) 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3Global Discovery Biosciences Announces Collaboration with IPMD, Inc. to Develop Innovative Aptamer-Based Blood Test for the Early Detection of Lung Cancer 2
... OctreoPharm Sciences GmbH, a Berlin-based specialist in nuclear ... received the worldwide exclusive license for the development ... The new Gallium-68-labeled radioactive contrast agent ... has the potential to selectively detect and monitor ...
... 2011 Avista Capital Partners, a leading private equity ... the departing Chief Executive Officer of Nycomed, as Healthcare ... the development of Nycomed during Avista,s ownership of the ... Limited for Euro 9.6 billion. Under Mr. ...
Cached Medicine Technology:OctreoPharm Sciences GmbH Granted Global and Exclusive License for Oncology Diagnostic Product 2Avista Capital Partners Appoints Hakan Bjorklund as Healthcare Operating Executive 2Avista Capital Partners Appoints Hakan Bjorklund as Healthcare Operating Executive 3
(Date:9/23/2014)... 2014 Mel Frank, also known as ... and harvesting marijuana. He is perhaps one of the ... he’ll be leading a special elective course on growing ... pm at Oaksterdam University in Oakland, California. ... nomenclature, harvesting and manicuring, and identifying preflowers and outdoor ...
(Date:9/23/2014)... September 23, 2014 Oaksterdam University has ... . In its first post, the University addresses the ... changing cannabis industry. , The cannabis industry is becoming ... is expecting an 18-month boost of more than $600 ... use pot sales. And, the new legal recreational marijuana ...
(Date:9/23/2014)... Mo. Infants, vocalizations throughout the first year ... and cooing to forming syllables and first words. ... amount of vocalizations may differ between hearing and ... that infant vocalizations are primarily motivated by infants, ... with profound hearing loss who received cochlear implants ...
(Date:9/23/2014)... 23, 2014 Florida Hospital Zephyrhills ... renovated Women’s Health Center on Wednesday, September 24. ... the specially designed center offers a new level ... County. The Women’s Health Center offers comprehensive women’s ... labor and delivery through The Baby Place®, and ...
(Date:9/23/2014)... 23, 2014 "The primary purpose of the ... an inventor from Sacramento, Ca.. "Call lights are often found ... hanging on the IV pole out of the patient's reach. ... call device whenever they need it, I created this caddy." ... the nurse call device within easy reach. The accessory ensures ...
Breaking Medicine News(10 mins):Health News:Special Elective Course Added to Oaksterdam University Schedule; Unique Opportunity to Learn From the “Godfather of Cannabis” Mel Frank on September 27, 2014 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:Infant cooing, babbling linked to hearing ability, MU researcher finds 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3
... cancer when it works with,the growth-promoting protein IL-3 and ... Tenn., Nov. 27 A gene called N-Myc,leads a ... is overexpressed,helping to trigger acute myeloid leukemia (AML) under ... conditions, according to,results of a mouse study done by ...
... CHAPEL HILL, N.C., Nov. 27 A story ... "colleague spam" -- the habit of,co-workers indiscriminately hitting ... New research by benchmarking leader Best Practices, LLC,uncovered ... spam" -- the,tendency of organizations to send redundant ...
... Failing Marks for Second Straight Year, WASHINGTON, Nov. ... Report Card on Lung Cancer. This,Report is an assessment ... state of Georgia. LCA-GA is a chapter of Lung ... patient support and,advocacy for people living with or at ...
... Nov. 27 The Aesthetic Extender,Symposium announced its inaugural ... which will be held in Miami Beach,Florida on October ... the first,and only event of its kind. Unlike other ... its mission statement a goal of adhering to,the policies ...
... Nov. 27 A new, free white ... on choosing the,right electronics manufacturing services (EMS) ... to download at, http://www.federalelec.com/medicalpaper ., Medical ... consistent quality and,conformance to product and regulatory ...
... E.S.T. - Positron emission tomography (PET) is a useful ... staging of lung cancer and improved treatment for patients, ... Journal of National Cancer Institute. , The ... of Cancer Care Ontarios Program in Evidence-Based Care led ...
Cached Medicine News:Health News:St. Jude Researchers Identify Key Genetic Trigger of Acute Myeloid Leukemia 2Health News:Using Efficient Communication to Boost Pharma Sales Force Productivity 2Health News:Lung Cancer Alliance-Georgia Issues Second Annual State-Specific Report Card on Lung Cancer 2Health News:Lung Cancer Alliance-Georgia Issues Second Annual State-Specific Report Card on Lung Cancer 3Health News:White Paper Details How to Choose the Right EMS Provider for Medical Products Outsourcing 2Health News:PET imaging significantly enhances standard imaging in lung cancer staging 2
The Properdin ELISA Kit is approved for in-vitro diagnostic use and measurement of properdin serum levels, relevant in cases of recurrent meningococcal infection and recurrent bacterial meningitis....
Inquire...
... can be used for a variety of vacuum needs ... or volatile fumes., Quiet running operation ... changes forever , Chemically Resistant ... solvents such as acids and organics. ...
High-intensity 300-watt xenon lamp, with continuously adjustable output from 0 to 100% manually or automatically by camera video output signal....
Medicine Products: